PARP1 and neoplasm: Surprisingly, however, the PARPi-resistant tumor cells retain their sensitivity to PARPi in vitro, suggesting that adaptive mechanisms operating in the tumor microenvironment protect these PARPi-sensitive cells from PARP inhibition in-vivo.